ACOR Financial Facts

Cost of sales: 13.48M
Net loss per share-basic (earnings per share): -0.03
See Full Income Statement

Accumulated deficit: -255.66M
Current portion of convertible notes payable: 1.14M
See Full Balance Sheet

Earnings History for Acorda Therapeutics, Inc. (ACOR)

  |   Expand Research on ACOR
Next EPS Date 7/30/13 *Est. EPS Growth Rate -75.0% *Last Qtr.
Average EPS % Beat Rate +108.6% Revenue Growth Rate -12.6% *Last Qtr.
Average % Move 1-Wk after EPS -2.1%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
11/4/11 Q311 $0.40$0.73 -$0.33$93.03M$90.78M N/A / N/A N/A +67.3% Details
5/2/13 Q113 $0.09$0.13 -$0.04$62.3M$80.71M N/A / N/A N/A -10.6% Details
2/13/13 Q412 $0.24$0.15 +$0.09$81.47M$78.9M N/A / N/A N/A +15.9% Details
10/31/12 Q312 $0.38$0.10 +$0.28$77.44M$75.2M N/A / N/A N/A +52.2% Details
7/31/12 Q212 $0.27$0.12 +$0.15$75.66M$72.55M N/A / N/A N/A +38.3% Details
5/3/12 Q112 $0.36$0.18 +$0.18$71.25M$70.95M N/A / N/A N/A +34.1% Details
2/16/12 Q411 $0.45$0.18 +$0.27$72.64M$69.16M N/A / N/A N/A +29.2% Details
8/1/11 Q211 $0.19$0.12 +$0.07$65.28M$66.29M N/A / N/A N/A +20.5% Details
Like ACOR Earnings? Also take a look at CAB, PETM, SUN

ACOR Earnings News